全部 标题 作者
关键词 摘要

OALib Journal期刊
ISSN: 2333-9721
费用:99美元

查看量下载量

相关文章

更多...
PLOS ONE  2014 

The Alarmin Concept Applied to Human Renal Transplantation: Evidence for a Differential Implication of HMGB1 and IL-33

DOI: 10.1371/journal.pone.0088742

Full-Text   Cite this paper   Add to My Lib

Abstract:

The endogenous molecules high mobility group box 1 (HMGB1) and interleukin-33 (IL-33) have been identified as alarmins, capable of mediating danger signals during tissue damage. Here, we address their possible role as innate-immune mediators in ischemia-reperfusion injury (IRI) following human kidney transplantation. We analysed serum and urinary HMGB1 and IL-33 levels, all determined by enzyme-linked immunosorbent assay, in a cohort of 26 deceased renal transplant recipients. Urinary HMGB1 and IL-33 levels were significantly increased as soon as 30 min after reperfusion, as compared to those before treatment. Moreover, both serum and urinary IL-33 (but not HMGB1) increase was positively correlated with cold ischemia time, from 30 min to 3 days post-transplantation. In vitro, human umbilical vein endothelial cells subjected to hypoxia conditions released both HMGB-1 and IL-33, while only the latter was further increased upon subsequent re-oxygenation. Finally, we postulate that leukocytes from renal recipient patients are targeted by both HMGB1 and IL-33, as suggested by increased transcription of their respective receptors (TLR2/4 and ST2L) shortly after transplantation. Consistent with this view, we found that iNKT cells, an innate-like T cell subset involved in IRI and targeted by IL-33 but not by HMGB1 was activated 1 hour post-transplantation. Altogether, these results are in keeping with a potential role of IL-33 as an innate-immune mediator during kidney IRI in humans.

References

[1]  Nankivell B, Chapman J (2006) Chronic Allograft Nephropathy: Current Concepts and Future Directions. Transplantation March 15, 2006 81: 643–654. doi: 10.1097/01.tp.0000190423.82154.01
[2]  Eltzschig HK, Eckle T (2011) Ischemia and reperfusion–from mechanism to translation. Nature Medicine 17: 1391–1401. doi: 10.1038/nm.2507
[3]  Thurman JM (2007) Triggers of inflammation after renal ischemia/reperfusion. Clinical Immunology 123: 7–13. doi: 10.1016/j.clim.2006.09.008
[4]  Meier-Kriesche H, Schold JD, Srinivas TR, Kaplan B (2004) Lack of Improvement in Renal Allograft Survival Despite a Marked Decrease in Acute Rejection Rates Over the Most Recent Era. American Journal of Transplantation 4: 378–383. doi: 10.1111/j.1600-6143.2004.00332.x
[5]  Bon D, Chatauret N, Giraud S, Thuillier R, Favreau F, et al. (2012) New strategies to optimize kidney recovery and preservation in transplantation. Nature Reviews Nephrology 8: 339–347. doi: 10.1038/nrneph.2012.83
[6]  Rao DA, Pober JS (2008) Endothelial injury, alarmins, and allograft rejection. Crit Rev Immunol 28: 229–248. doi: 10.1615/critrevimmunol.v28.i3.40
[7]  Gallucci S, Matzinger P (2001) Danger signals: SOS to the immune system. Current Opinion in Immunology 13: 114–119. doi: 10.1016/s0952-7915(00)00191-6
[8]  Müller S, Ronfani L, Bianchi ME (2004) Regulated expression and subcellular localization of HMGB1, a chromatin protein with a cytokine function. Journal of Internal Medicine 255: 332–343. doi: 10.1111/j.1365-2796.2003.01296.x
[9]  Matsuoka N, Itoh T, Watarai H, Sekine-Kondo E, Nagata N, et al. (2010) High-mobility group box 1 is involved in the initial events of early loss of transplanted islets in mice. Journal of Clinical Investigation 120: 735–743. doi: 10.1172/jci41360
[10]  Tsung A, Klune JR, Zhang X, Jeyabalan G, Cao Z, et al. (2007) HMGB1 release induced by liver ischemia involves Toll-like receptor 4–dependent reactive oxygen species production and calcium-mediated signaling. J Exp Med 204: 2913–2923. doi: 10.1084/jem.20070247
[11]  Li J, Gong Q, Zhong S, Wang L, Guo H, et al. (2011) Neutralization of the extracellular HMGB1 released by ischaemic-damaged renal cells protects against renal ischaemia–reperfusion injury. Nephrol Dial Transplant 26: 469–478. doi: 10.1093/ndt/gfq466
[12]  Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, et al. (2010) HMGB1 Contributes to Kidney Ischemia Reperfusion Injury. Journal of the American Society of Nephrology 21: 1878–1890. doi: 10.1681/asn.2009101048
[13]  Kuhlicke J, Frick JS, Morote-Garcia JC, Rosenberger P, Eltzschig HK (2007) Hypoxia Inducible Factor (HIF)-1 Coordinates Induction of Toll-Like Receptors TLR2 and TLR6 during Hypoxia. PLoS ONE 2: e1364. doi: 10.1371/journal.pone.0001364
[14]  Powers KA, Szászi K, Khadaroo RG, Tawadros PS, Marshall JC, et al. (2006) Oxidative stress generated by hemorrhagic shock recruits Toll-like receptor 4 to the plasma membrane in macrophages. J Exp Med 203: 1951–1961. doi: 10.1084/jem.20060943
[15]  Leemans JC, Stokman G, Claessen N, Rouschop KM, Teske GJD, et al. (2005) Renal-associated TLR2 mediates ischemia/reperfusion injury in the kidney. J Clin Invest 115: 2894–2903. doi: 10.1172/jci22832
[16]  Krüger B, Krick S, Dhillon N, Lerner SM, Ames S, et al. (2009) Donor Toll-like receptor 4 contributes to ischemia and reperfusion injury following human kidney transplantation. Proc Natl Acad Sci U S A 106: 3390–3395. doi: 10.1073/pnas.0810169106
[17]  Ali S, Huber M, Kollewe C, Bischoff SC, Falk W, et al. (2007) IL-1 receptor accessory protein is essential for IL-33-induced activation of T lymphocytes and mast cells. Proc Natl Acad Sci U S A 104: 18660–18665. doi: 10.1073/pnas.0705939104
[18]  Schmitz J, Owyang A, Oldham E, Song Y, Murphy E, et al. (2005) IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines. Immunity 23: 479–490. doi: 10.1016/j.immuni.2005.09.015
[19]  Moussion C, Ortega N, Girard J-P (2008) The IL-1-Like Cytokine IL-33 Is Constitutively Expressed in the Nucleus of Endothelial Cells and Epithelial Cells In Vivo: A Novel “Alarmin”? PLoS ONE 3: e3331. doi: 10.1371/journal.pone.0003331
[20]  Haraldsen G, Balogh J, Pollheimer J, Sponheim J, Küchler AM (2009) Interleukin-33- cytokine of dual function or novel alarmin? Trends in Immunology 30: 227–233. doi: 10.1016/j.it.2009.03.003
[21]  Akcay A, Nguyen Q, He Z, Turkmen K, Won Lee D, et al. (2011) IL-33 Exacerbates Acute Kidney Injury. Journal of the American Society of Nephrology 22: 2057–2067. doi: 10.1681/asn.2010091011
[22]  Bao Y-S, Na S-P, Zhang P, Jia X-B, Liu R-C, et al. (2012) Characterization of Interleukin-33 and Soluble ST2 in Serum and Their Association with Disease Severity in Patients with Chronic Kidney Disease. J Clin Immunol 32: 587–594. doi: 10.1007/s10875-011-9622-7
[23]  Sakai N, Van Sweringen HL, Quillin RC, Schuster R, Blanchard J, et al. (2012) Interleukin-33 is hepatoprotective during liver ischemia/reperfusion in mice. Hepatology: 56 (4).
[24]  Wagenaar JFP, Gasem MH, Goris MGA, Leeflang M, Hartskeerl RA, et al. (2009) Soluble ST2 Levels Are Associated with Bleeding in Patients with Severe Leptospirosis. PLoS Neglected Tropical Diseases 3: e453. doi: 10.1371/journal.pntd.0000453
[25]  Sanada S, Hakuno D, Higgins LJ, Schreiter ER, McKenzie ANJ, et al. (2007) IL-33 and ST2 comprise a critical biomechanically induced and cardioprotective signaling system. J Clin Invest 117: 1538–1549. doi: 10.1172/jci30634
[26]  Rabadi MM, Kuo M-C, Ghaly T, Rabadi SM, Weber M, et al. (2012) Interaction between uric acid and HMGB1 translocation and release from endothelial cells. American Journal of Physiology - Renal Physiology 302: F730–F741. doi: 10.1152/ajprenal.00520.2011
[27]  Mullins GE, Sunden-Cullberg J, Johansson A-S, Rouhiainen A, Erlandsson-Harris H, et al. (2004) Activation of Human Umbilical Vein Endothelial Cells Leads to Relocation and Release of High-Mobility Group Box Chromosomal Protein 1. Scandinavian Journal of Immunology 60: 566–573. doi: 10.1111/j.0300-9475.2004.01518.x
[28]  Li L, Huang L, Sung SJ, Lobo PI, Brown MG, et al. (2007) NKT Cell Activation Mediates Neutrophil IFN-γ Production and Renal Ischemia-Reperfusion Injury. The Journal of Immunology 178: 5899–5911. doi: 10.4049/jimmunol.178.9.5899
[29]  Bourgeois E, Van LP, Samson M, Diem S, Barra A, et al. (2009) The pro-Th2 cytokine IL-33 directly interacts with invariant NKT and NK cells to induce IFN-γ production. European Journal of Immunology 39: 1046–1055. doi: 10.1002/eji.200838575
[30]  Smithgall MD, Comeau MR, Park Yoon B-R, Kaufman D, Armitage R, et al. (2008) IL-33 amplifies both Th1- and Th2-type responses through its activity on human basophils, allergen-reactive Th2 cells, iNKT and NK Cells. International Immunology 20: 1019–1030. doi: 10.1093/intimm/dxn060
[31]  Apetoh L, Ghiringhelli F, Tesniere A, Obeid M, Ortiz C, et al. (2007) Toll-like receptor 4–dependent contribution of the immune system to anticancer chemotherapy and radiotherapy. Nature Medicine 13: 1050–1059. doi: 10.1038/nm1622
[32]  Oboki K, Ohno T, Kajiwara N, Arae K, Morita H, et al. (2010) IL-33 is a crucial amplifier of innate rather than acquired immunity. PNAS 107: 18581–18586. doi: 10.1073/pnas.1003059107
[33]  Bourgeois EA, Levescot A, Diem S, Chauvineau A, Bergès H, et al. (2011) A natural protective function of invariant NKT cells in a mouse model of innate-cell-driven lung inflammation. European Journal of Immunology 41: 299–305. doi: 10.1002/eji.201040647
[34]  Wolfs TGAM, Buurman WA, Schadewijk A van, Vries B de, Daemen MARC, et al. (2002) In Vivo Expression of Toll-Like Receptor 2 and 4 by Renal Epithelial Cells: IFN-γ and TNF-α Mediated Up-Regulation During Inflammation. J Immunol 168: 1286–1293. doi: 10.4049/jimmunol.168.3.1286
[35]  Chen J, John R, Richardson JA, Shelton JM, Zhou XJ, et al. (2011) Toll-like receptor 4 regulates early endothelial activation during ischemic acute kidney injury. Kidney International 79: 288–299. doi: 10.1038/ki.2010.381
[36]  Krüger B, Yin N, Zhang N, Yadav A, Coward W, et al. (2010) Islet-expressed TLR2 and TLR4 sense injury and mediate early graft failure after transplantation. European Journal of Immunology 40: 2914–2924. doi: 10.1002/eji.201040601
[37]  Fagundes CT, Amaral FA, Souza ALS, Vieira AT, Xu D, et al. (2007) ST2, an IL-1R family member, attenuates inflammation and lethality after intestinal ischemia and reperfusion. J Leukoc Biol 81: 492–499. doi: 10.1189/jlb.0606422
[38]  Mirchandani AS, Salmond RJ, Liew FY (2012) Interleukin-33 and the function of innate lymphoid cells. Trends in Immunology 33: 389–396. doi: 10.1016/j.it.2012.04.005
[39]  Liu A, Jin H, Dirsch O, Deng M, Huang H, et al. (2010) Release of Danger Signals during Ischemic Storage of the Liver: A Potential Marker of Organ Damage? Mediators of Inflammation 2010: 1–11. doi: 10.1155/2010/436145
[40]  Goffic RL, Arshad MI, Rauch M, L’Helgoualc’h A, Delmas B, et al. (2011) Infection with Influenza Virus Induces IL-33 in Murine Lungs. Am J Respir Cell Mol Biol 45: 1125–1132. doi: 10.1165/rcmb.2010-0516oc
[41]  Matsuyama Y, Okazaki H, Hoshino M, Onishi S, Kamata Y, et al. (2012) Sustained elevation of interleukin-33 in sera and synovial fluids from patients with rheumatoid arthritis non-responsive to anti-tumor necrosis factor: possible association with persistent IL-1β signaling and a poor clinical response. Rheumatol Int 32: 1397–1401. doi: 10.1007/s00296-011-1854-6
[42]  Salahudeen AK, Haider N, May W (2004) Cold ischemia and the reduced long-term survival of cadaveric renal allografts. Kidney International 65: 713–718. doi: 10.1111/j.1523-1755.2004.00416.x
[43]  Yin H, Li X-Y, Jin X-B, Zhang B-B, Gong Q, et al. (2010) IL-33 Prolongs Murine Cardiac Allograft Survival Through Induction of TH2-Type Immune Deviation. Transplantation 89: 1189–1197. doi: 10.1097/tp.0b013e3181d720af
[44]  Brunner SM, Schiechl G, Falk W, Schlitt HJ, Geissler EK, et al. (2011) Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transplant International 24: 1027–1039. doi: 10.1111/j.1432-2277.2011.01306.x
[45]  Turnquist HR, Zhao Z, Rosborough BR, Liu Q, Castellaneta A, et al. (2011) IL-33 expands suppressive CD11b+ Gr-1int and regulatory T cells (Treg), including ST2L+ Foxp3+ cells, and mediates Treg-dependent promotion of cardiac allograft survival. J Immunol 187: 4598–4610. doi: 10.4049/jimmunol.1100519

Full-Text

Contact Us

service@oalib.com

QQ:3279437679

WhatsApp +8615387084133